MICAFUNGIN TEVA 50 MG

Country: Israel

Language: English

Source: Ministry of Health

Active ingredient:

MICAFUNGIN AS SODIUM

Available from:

TEVA ISRAEL LTD

ATC code:

J02AX05

Pharmaceutical form:

POWDER FOR SOLUTION FOR INFUSION

Composition:

MICAFUNGIN AS SODIUM 50 MG

Administration route:

I.V

Prescription type:

Required

Manufactured by:

TEVA ISRAEL LTD, ISRAEL

Therapeutic area:

MICAFUNGIN

Therapeutic indications:

Micafungin Teva is indicated for: Adults, adolescents ≥ 16 years of age and elderly: - Treatment of invasive candidiasis. - Treatment of oesophageal candidiasis in patients for whom intravenous therapy is appropriate. - Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation. Children (including neonates) and adolescents < 16 years of age: - Treatment of invasive candidiasis. - Prophylaxis of Candida infection in patients undergoing allogeneic haematopoietic stem cell transplantation. The decision to use Micafungin Teva should take into account a potential risk for the development of liver tumors. Micafungin Teva should therefore only be used if other antifungals are not appropriate.

Authorization date:

2023-02-23